共 37 条
- [1] Rose N.R., Prediction and prevention of autoimmune disease in the 21st century: a review and preview, Am J Epidemiol, 183, 5, pp. 403-406, (2016)
- [2] Conrad N., Misra S., Verbakel J.Y., Et al., Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK, Lancet, 401, pp. 1878-1890, (2023)
- [3] Xu Q., Ni J.J., Han B.X., Et al., Causal relationship between gut microbiota and autoimmune diseases: a two-sample Mendelian randomization study, Front Immunol, 12, (2021)
- [4] Ward M.M., Chapter 19 - Epidemiology of SLE and related diseases: Incidence, prevalence, and mortality, Lahita’s Systemic Lupus Erythematosus (Sixth Edition), pp. 291-304, (2021)
- [5] Wu L., Lin H., Hu Y., Et al., The major causes and risk factors of total and cause-specific mortality during 5.4-year follow-up: the Shanghai Changfeng study, Eur J Epidemiol, 34, 10, pp. 939-949, (2019)
- [6] Kurosaka D., Yasuda J., Yoshida K., Et al., Telomerase activity and telomere length of peripheral blood mononuclear cells in SLE patients, Lupus, 12, 8, pp. 591-599, (2003)
- [7] Steer S.E., Williams F.M.K., Kato B., Et al., Reduced telomere length in rheumatoid arthritis is independent of disease activity and duration, Ann Rheum Dis, 66, 4, pp. 476-480, (2007)
- [8] Artlett C.M., Black C.M., Briggs D.C., Stevens C.O., Welsh K.I., Telomere reduction in scleroderma patients: a possible cause for chromosomal instability, Br J Rheumatol, 35, 8, pp. 732-737, (1996)
- [9] Jeanclos E., Krolewski A., Skurnick J., Et al., Shortened telomere length in white blood cells of patients with IDDM, Diabetes, 47, 3, pp. 482-486, (1998)
- [10] Davey Smith G., Hemani G., Mendelian randomization: genetic anchors for causal inference in epidemiological studies, Hum Mol Genet, 23, R1, pp. R89-R98, (2014)